Major Health NewsHealth, biotech and life sciences releases

Press Release · EB Research Partnership

Eddie Vedder, Hozier, Tom Holland and Colin Farrell Help Raise Over $3 Million for EB Research Partnership at New York Gala

Distributed by Major Health News · Originally issued via PR Newswire

Nearly 700 guests came together for a night of music, scientific progress and a shared determination to cure Epidermolysis Bullosa.

NEW YORK, Nov. 20, 2026 — Nearly 700 people gathered at Pier Sixty in New York City on November 11 with one goal: to accelerate treatments and a cure for EB.

By the end of the night, they had raised more than $3 million.

From left to right: Michael Hund, CEO of EB Research Partnership; Olivia Vedder; Hozier; Eddie Vedder and Jill Vedder, co-founders of EB Research Partnership; and Colin Farrell at Venture Into Cures. Photo credit: Sachyn Mital
From left to right: Jill Vedder, Robbie Twible, Eddie Vedder, Kalilla Dilgen, Chris Ulmer, Faye Dilgen and Teague Dilgen during the John Hudson Ambassadorship Award presentation at Venture Into Cures. Photo credit: Sachyn Mital
From left to right: Jill Vedder, Robbie Twible, Eddie Vedder, Kalilla Dilgen, Chris Ulmer, Faye Dilgen and Teague Dilgen during the John Hudson Ambassadorship Award presentation at Venture Into Cures. Photo credit: Sachyn Mital
From left to right: Sean Casey, Dr. Jeff Heddles, Elodie Kubik, Marc Seidner and event host Liz Trinnear celebrate the presentation of the
Venture Into Cures Leadership Awards, recognizing Dr. Heddles and Seidner for their dedication to advancing EB Research Partnership’s mission. Photo credit: Yekaterina Gyadu
From left to right: Sean Casey, Dr. Jeff Heddles, Elodie Kubik, Marc Seidner and event host Liz Trinnear celebrate the presentation of the Venture Into Cures Leadership Awards, recognizing Dr. Heddles and Seidner for their dedication to advancing EB Research Partnership’s mission. Photo credit: Yekaterina Gyadu
From left to right: Michael Hund, CEO of EB Research Partnership; Olivia Vedder; Hozier; Eddie Vedder and Jill Vedder, co-founders of EB Research Partnership; and Colin Farrell at Venture Into Cures.
Photo credit: Sachyn Mital From left to right: Jill Vedder, Robbie Twible, Eddie Vedder, Kalilla Dilgen, Chris Ulmer, Faye Dilgen and Teague Dilgen during the John Hudson Ambassadorship Award presentation at Venture Into Cures. Photo credit: Sachyn Mital From left to right: Sean Casey, Dr. Jeff Heddles, Elodie Kubik, Marc Seidner and event host Liz Trinnear celebrate the presentation of the
Venture Into Cures Leadership Awards, recognizing Dr. Heddles and Seidner for their dedication to advancing EB Research Partnership’s mission. Photo credit: Yekaterina Gyadu

Nearly 700 guests raised over $3 million for EB research as Eddie Vedder welcomed surprise guest Hozier onstage.

Post this

The event was Venture Into Cures, the signature gala of EB Research Partnership (EBRP), a nonprofit dedicated to curing epidermolysis bullosa (EB). Often called "Butterfly Disease," EB is a rare and life-threatening genetic condition that makes skin so fragile it can blister and tear from the slightest touch. While there is still no cure, breakthroughs in research and new treatments are bringing hope to families living with the disease.

EBRP co-founders Jill and Eddie Vedder stood alongside families living with EB, world-class scientists and leaders from healthcare, finance and industry, all united by the belief that EB will be cured.

"We have reached a remarkable moment in EB, progress that once seemed impossible is now happening before our eyes. We have gone from zero FDA-approved treatments to three, while clinical trials have increased 25-fold. Venture Into Cures is more than a celebration of how far we've come, it is a declaration that we are not slowing down. Together, we will keep pushing the boundaries of what is possible until treatments and cures reach every patient and family who needs them," said Michael Hund, CEO of EBRP.

The evening's biggest musical moment came when Eddie Vedder introduced a surprise guest: Hozier. The Irish singer-songwriter took the stage in support of EBRP and its mission to cure EB, delivering a three-song performance that brought the house down.

The program also featured comedian Sam Morril, who opened the evening, and television personality and etalk correspondent Liz Trinnear, who lives with EB simplex and served as host. Longtime EBRP supporter Tom Holland, who hosted the gala in 2021, delivered a personal video message introducing the evening's impact film.

Academy Award-nominated actor Colin Farrell joined guests in support of the EB community. His upcoming documentary, The Slightest Touch, explores his friendship with EB advocate Emma Fogarty and premieres November 25 on HBO Max. The film continues the momentum generated by Matter of Time, the Netflix documentary that brought EBRP's work and the search for a cure to audiences around the world.

The night's biggest moments

  • Archer's story. Host Liz Trinnear introduced Archer and his dad, Kirk Brazeau, whose family shared their life with EB in a short film.
  • Celebrating scientific breakthroughs. Introduced by Hodges Caldwell Jr. and Vanessa Leinert, Dr. Jean Tang of Stanford University presented the Innovation & Impact Award to Children's Hospital Colorado, accepted by Dr. James Feinstein, and the University of Colorado Anschutz, accepted by Dr. Ganna Bilousova. CU Anschutz is pioneering gene-corrected stem cell therapies for EB, and Children's Hospital Colorado is leading research to better detect and treat aggressive skin cancers in people living with EB.
  • Honoring John Hudson. In a moving tribute led by Chris Ulmer, founder of Special Books by Special Kids, EBRP Board Member Faye Dilgen honored her son, John Hudson Dilgen, who lived with EB and passed away earlier this year. One of the EB community's most powerful voices, John Hudson reached millions and inspired more than $720,000 in support of EB research. Faye presented the award named in his honor, the John Hudson Ambassadorship Award, to Robbie Twible. Robbie, who also lives with EB, carries that spirit forward, using his voice to raise awareness and build a brighter future for everyone living with EB.
  • A surprise for Faye. EBRP Co-Founder and Chairwoman Jill Vedder then presented Faye with a second John Hudson Ambassadorship Award for her relentless commitment to the EB community.
  • The paddles went up. Guests gave over $1.3 million during the paddle raise and the live auction of two guitars signed by Eddie Vedder and his Pearl Jam bandmates.
  • Celebrating leadership. Three Venture Into Cures Leadership Awards honored commitment to expanding EBRP's mission and bringing new supporters into the space. Carl Hess, CEO of Willis Towers Watson, presented to his colleague Glenn McGrath, the firm's Executive Vice President. Elodie Kubik presented to Marc Seidner, PIMCO investment leader and EBRP Board Member, and Dr. Jeff Heddles, philanthropist and EB research advocate. A young girl living with EB, Elodie is the inspiration behind Plunge for Elodie, a global polar plunge that raises awareness for EB. Former MLB All-Star Sean Casey joined them on stage with a playful surprise, an EBRP Speedo for each honoree and an invitation to take the Plunge for Elodie in 2027.
  • Remembering Ari Deshe. The night paid tribute to the late Ari Deshe, a longtime EBRP Board Member born with EB simplex, whose leadership helped build the foundation for today's progress.
  • A closing for the ages. Eddie Vedder introduced surprise guest Hozier to perform a set of songs. His performance brought one of music's most celebrated voices to the EB community and a global spotlight to a disease too few people know.
  • An after-party to remember. EBRP brought DJ Santy Monarka all the way from Bogotá, Colombia, for a special after-party performance. A talented young DJ living with EB, Santy was joined by his friend and collaborator, violinist and singer Nicolas Cordoba Shaw. Together they brought vibrant energy to the celebration and kept the dance floor full.

"Not long ago, families living with EB were told science had nothing to offer them. Today we have approved treatments and a pipeline full of promise, because this community funded the work before anyone else would. Children's Hospital Colorado and CU Anschutz show what's possible when bold science and compassionate care move together," said Dr. Jean Tang.

"John Hudson used his voice to help the world understand EB. Watching Robbie carry that same spirit forward means more than I can say. John Hudson's greatest wish was that the children who come after him would never know the pain he lived with, and tonight this room brought that wish closer," said Faye Dilgen.

"What makes EB Research Partnership extraordinary is its ability to unite groundbreaking science with an unwavering commitment to the families at the heart of this mission. Every individual I've introduced to this organization has come away with a profound understanding of both the urgency and the opportunity before us. I'm committed to seeing this work through until EB is cured," said Glenn McGrath.

A model built to cure

EBRP exists to cure EB. Founded in 2010 by families alongside Jill and Eddie Vedder, it is the largest global nonprofit dedicated to EB research. EBRP backs the most promising science early, when funding matters most, and pushes it toward patients fast.

Since 2010, EBRP has raised over $96 million, funded over 200 research projects across 22 countries, and active EB clinical trials have grown from 2 to 50. In 2023, the FDA approved the first treatments ever for EB. Today there are three, two of which were built on science EBRP helped fund early.

Breakthrough science often stalls for lack of early funding. EBRP's unique Venture Philanthropy model was built to change that. Unlike traditional grantmaking, EBRP takes a financial interest in the research it funds. When a therapy succeeds, the return flows back into new research until there is a cure, so every gift keeps working long after it's given. Forbes, Harvard Business School, MIT Solve, the Milken Institute and Stanford Social Innovation Review have all recognized the model for its innovative technique.

What works for EB can work for more than 10,000 rare diseases affecting 400 million people worldwide, 95% of which still lack an approved treatment. That model is already scaling. Rare Ventures, launched with up to $25 million from the Richard King Mellon Foundation, unites EBRP with UPMC Children's Hospital of Pittsburgh, UPMC Vision Institute, Carnegie Mellon University, Stanford Medicine and ElevateBio to speed therapies for rare diseases.

Venture Into Cures was presented by Willis Towers Watson (WTW) and The McGrath Family, with generous support from Titanium sponsors The Seidner Family and Turtle Pond Foundation and Platinum sponsors The Finkelstein Family and The Oros Family. Thank you to all of the event's Partners in Flight, listed at ebresearch.org/vic2026.

SOURCE EB Research Partnership

About EB Research Partnership

Founded in 2010 by a group of families and Jill and Eddie Vedder, EB Research Partnership (EBRP) is the largest global nonprofit dedicated to curing epidermolysis bullosa (EB), a rare genetic disease that makes skin blister and tear at the slightest touch. Through its venture philanthropy model, EBRP funds the most promising science early and reinvests any return from successful therapies into more research until there is a cure. Its approach is a blueprint for thousands of other rare diseases. With offices in the US and Australia, EBRP directs 100% of every gift to research, thanks to angel donors who cover operations. Learn more at www.ebresearch.org.

Photos and video are available at https://drive.google.com/drive/folders/1cprIl0lQ4H_n68gcc4lHPhq0R2sKh4Ul?usp=sharing